🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to evaluate whether hypofractionated who...
Status
Recruiting
Location
Siriraj Hospital
Start Date
2026-08-03
Trial ID
NCT07709650
Treatments Being Tested
Retinoblastoma is a childhood cancer which affects the retina of the eye. T...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2005-04-07
Trial ID
NCT00186888
RATIONALE: Androgens can cause the growth of prostate cancer cells. Antihor...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2000-04
Trial ID
NCT00684905
The purpose of this study is to evaluate the safety, performance and usabil...
Status
Completed
Location
Oklahoma University
Start Date
2013-11
Trial ID
NCT01851772
Treatments Being Tested
Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation t...
Status
Completed
Location
University of Miami
Start Date
2012-01
Trial ID
NCT01485731
Prospective cohort study comparing robot-assisted radical prostatectomy and...
Status
Recruiting
Location
Noordwest Ziekenhuisgroep
Start Date
2023-02-16
Trial ID
NCT05931419
This will be a multi-institution, single-arm, open-label, phase I/II trial....
Status
Completed
Location
Princess Margaret Hospital
Start Date
2007-06
Trial ID
NCT00510250
The purpose of this trial is to compare two similar treatments for patients...
Status
Unknown
Location
BC Cancer Agency
Start Date
2004-05
Trial ID
NCT00175396
This study will treat participants with newly diagnosed, low, intermediate ...
Status
Active Not Recruiting
Location
University of Florida Proton Therapy Institute
Start Date
2013-12-04
Trial ID
NCT01871766
To observe the efficacy and safety of hydrochloride anlotinib combined with...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05772377
Treatments Being Tested